Today's Nifty Pharma Index Price
As of June 25, 2025, the Nifty Pharma index is trading at Rs. 21,797.55. The index has shown a positive movement today, reflecting strength in the pharmaceutical sector.
For the most current, regularly updated Nifty Pharma share price, please refer to the live ticker section located above on this page. That section provides a real-time share price summary, including the top gainer loser stocks daily.
Investors looking for the Nifty Pharma live price and Nifty Pharma price chart can find detailed information in our dedicated live market data section.
Nifty Pharma Historical Returns
The Nifty Pharma index has displayed the following historical returns as of June 25, 2025:
-
1 Week: -2.01% (as of June 20, 2025)
-
1 Month: -0.67% (as of June 20, 2025)
-
3 Months: +2.12% (as of June 20, 2025)
-
6 Months: -4.86% (as of June 20, 2025)
-
1 Year: +9.92% (as of June 20, 2025)
The Nifty Pharma performance shows some short-term volatility, with negative returns over the past week and month. However, the 3-month and 1-year returns indicate a positive long-term trend, suggesting underlying resilience and growth in the pharmaceutical sector. This performance highlights the sector's ability to recover from short-term corrections and deliver returns over a longer investment horizon, driven by fundamental factors.
Nifty Pharma News and Updates
Several key developments around June 25, 2025, are impacting the Nifty Pharma index:
-
New Drug Launches and Approvals: Glenmark Pharmaceuticals saw its shares rise by 3% today after launching its cancer drug Tevimbra in India, following approval from the Central Drugs Standard Control Organisation (CDSCO). Similarly, Aurobindo Pharma's subsidiary CuraTeQ Biologics received UK MHRA approval for Dyrupeg, a biosimilar, marking its third biosimilar approval in 2025. JB Chemicals & Pharmaceuticals also secured USFDA approval for its generic antidepressant. Such new launches and approvals are significant drivers for individual Nifty Pharma stocks and the overall index.
-
Global Market Sentiment: While the broader Indian market is generally positive today due to easing geopolitical tensions and optimistic global cues, the pharma sector often reacts to specific industry news. The appreciation of the Indian Rupee against the US Dollar and a decline in crude oil prices are generally favourable for the Indian economy, which can indirectly benefit the Nifty Pharma index through improved economic stability.
-
Company-Specific Developments: Individual companies within the Nifty Pharma stocks list are seeing varied movements. While some, like Glenmark, are gaining on specific news, others might be experiencing corrections or consolidation. Major constituents such as Sun Pharmaceutical Industries, Divi's Laboratories, Cipla, and Dr. Reddy's Laboratories, due to their significant weightage, heavily influence the Nifty Pharma index. Investors are closely watching their upcoming corporate actions, including dividend declarations, such as those by Cipla, Sun Pharma, and Zydus Lifesciences in July.
These factors affecting Nifty Pharma are crucial for investors tracking the Indian stock market update, especially those interested in the healthcare and pharmaceutical sectors.